These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 17112788

  • 1. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA, Williams JM, Imig JD, Pollock JS, Pollock DM.
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [Abstract] [Full Text] [Related]

  • 2. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA, Mann G, Walton M, Eatman D.
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
    Banday AA, Lokhandwala MF.
    Hypertension; 2008 Dec 15; 52(6):1099-105. PubMed ID: 18955661
    [Abstract] [Full Text] [Related]

  • 7. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI, Della Penna SL, Cao G, Gorzalczany S, Pandolfo M, Toblli JE, Fernández BE.
    J Cell Physiol; 2010 Jul 15; 224(1):41-8. PubMed ID: 20232302
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1/2-RSK signaling pathway to modulate central control of blood pressure.
    Cheng WH, Lu PJ, Ho WY, Tung CS, Cheng PW, Hsiao M, Tseng CJ.
    Circ Res; 2010 Mar 05; 106(4):788-95. PubMed ID: 20056918
    [Abstract] [Full Text] [Related]

  • 10. Increased renal medullary H2O2 leads to hypertension.
    Makino A, Skelton MM, Zou AP, Cowley AW.
    Hypertension; 2003 Jul 05; 42(1):25-30. PubMed ID: 12782642
    [Abstract] [Full Text] [Related]

  • 11. Role of the renin-angiotensin system, renal sympathetic nerve system, and oxidative stress in chronic foot shock-induced hypertension in rats.
    Dong T, Chen JW, Tian LL, Wang LH, Jiang RD, Zhang Z, Xu JB, Zhao XD, Zhu W, Wang GQ, Sun WP, Zhang GX.
    Int J Biol Sci; 2015 Jul 05; 11(6):652-63. PubMed ID: 25999788
    [Abstract] [Full Text] [Related]

  • 12. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats.
    Hoagland KM, Maier KG, Roman RJ.
    Hypertension; 2003 Mar 05; 41(3 Pt 2):697-702. PubMed ID: 12623982
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme.
    Becari C, Teixeira FR, Oliveira EB, Salgado MC.
    Am J Physiol Heart Circ Physiol; 2011 Aug 05; 301(2):H565-70. PubMed ID: 21602471
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb 05; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 17. Cardioprotective effect of enalapril in renovascular and angiotensin II hypertension.
    Herizi A, Demeilliers B, Jover B, Mimran A.
    Clin Exp Hypertens; 1997 Feb 05; 19(5-6):953-64. PubMed ID: 9247767
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
    Rugale C, Delbosc S, Mimran A, Jover B.
    J Cardiovasc Pharmacol; 2007 Sep 05; 50(3):293-8. PubMed ID: 17878758
    [Abstract] [Full Text] [Related]

  • 20. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, Nurminen ML.
    Br J Pharmacol; 2000 Jul 05; 130(6):1339-47. PubMed ID: 10903974
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.